Genmab A (GMAB) Liabilities and Shareholders Equity (2023 - 2026)
Genmab A (GMAB) reported Liabilities and Shareholders Equity of $12.52 billion for the quarter ended Jun 30, 2026, up 1.1% from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Genmab A posted Liabilities and Shareholders Equity of $12.87 billion, up 202.0% from the prior year.
- Liabilities and Shareholders Equity has increased for seven consecutive years, with a five-year compound annual growth rate of 39.3% (years ended Dec 2020 to Dec 2025).
- By year, Liabilities and Shareholders Equity came in at $4.26 billion in the year ended Dec 31, 2024 (+28.0%), $3.33 billion in the year ended Dec 31, 2023 (+18.5%), $2.81 billion in the year ended Dec 31, 2022 (+1.0%) and $2.78 billion in the year ended Dec 31, 2021 (+13.3%).
- Five-year quarterly Liabilities and Shareholders Equity spans a low of $904.2 million in the quarter ended Sep 30, 2025 and a high of $12.87 billion in the quarter ended Dec 31, 2025.
- Year over year, Liabilities and Shareholders Equity gained in three of the last four quarters, with growth averaging 58.3%.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was the quarter ended Dec 31, 2025 (growth of 202.0%); the low point was the quarter ended Sep 30, 2021 (a decline of 87.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Genmab A | 2.56 Bn | -2.81 Bn | 1.07 Bn | 12.52 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.52 Bn |
| Mar 31, 2026 | 12.38 Bn |
| Dec 31, 2025 | 12.87 Bn |
| Sep 30, 2025 | 904.20 Mn |
| Jun 30, 2025 | 6.46 Bn |
| Mar 31, 2025 | 6.59 Bn |
| Dec 31, 2024 | 6.41 Bn |
| Dec 31, 2023 | 5.23 Bn |
| Jan 1, 2023 | 4.32 Bn |
API Access
Genmab A Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();